A French drugmaker aims to develop an affordable treatment for Charcot-Marie-Tooth, Stat News reports.
In Nature this week: ancient British genomes highlight influence of migration, and more.
A new report from the National Science Foundation examines the state of science and engineering in developed and developing nations.
Johnson & Johnson announced that it would be cutting about 3,000 jobs from its medical devices section.
An "Identify the Missing" Day has used DNA to identify the remains of a missing California woman, the AP reports.
In Nucleic Acids Research this week: methylation patterns in Mycobacterium tuberculosis, statistical approach to uncover alternative splicing patterns, and more.
Controversy swirls around the Broad Institute's Eric Lander's perspective piece on CRISPR that appeared in Cell last week.
A new survey looks into sexism and sexual harassment in Silicon Valley, Vox reports.
Researchers are embarking on a large genetics project to determine when and where dogs arose, the New York Times reports.
In PNAS this week: driver mutations and potential biomarkers for uterine fibroids, vitiligo risk variant characterized, and more.
A party thrown to coincide with a biotech conference hired models to make up for the lack of women, Bloomberg Business reports.
The 100,000 Genomes Project has diagnosed its first children with rare diseases, the BBC reports.
In PLOS this week: geogenetic maps, mutations linked to retinal dystrophy, and more.
Researchers and others wonder whether a cure for cancer is a goal that can be achieved.
Eating a Western diet for generations takes a toll on the gut microbiome, a new study says.
A Government Accountability Office report finds fault with FDA's post-market safety tracking.
In Science this week: how Cas9 identifies its target DNA, and more.
The UK Human Fertilisation & Embryology Authority is to consider an application submitted by researchers seeking to perform gene editing on human embryos.
Robert Califf's nomination as commissioner of the Food and Drug Administration clears Senate committee, but obstacles remain.
In a report, the Federation of American Societies for Experimental Biology presents its recommendations for addressing reproducibility in science.
In Nature this week: using CRISPR/Cas9 in functional genetic screens and more.
In his last State of the Union address, US President Barack Obama announced a "moonshot" to cure cancer, led by Vice President Joe Biden.
MedCity News says the real highlight of the JP Morgan Healthcare conference was when 23andMe CEO Anne Wojcicki was shushed for talking during her own company's presentation.
A New York Times reader wonders whether tissues are a good source of DNA evidence.
In Cell this week: changes to a gene regulatory region led to human foot form, long non-coding RNA NORAD contributes to genomic stability, and more.